Reni J. Benjamin

Reni J. Benjamin

Director/Miembro de la Junta en Centre For Commercialization of Regenerative Medicine .

Finance
Consumer Services
Health Technology

Perfil

Dr. Reni J.
Benjamin
is an Equity Research Analyst at Citizens JMP Securities LLC.
He is on the Board of Directors at Centre For Commercialization of Regenerative Medicine.
He is covering biotechnology.
He currently serves on the advisory board of Phacilitate Cell & Gene Therapy.
Dr. Benjamin joins JMP Securities from Raymond James, where he was a managing director and senior research analyst.
Dr. Benjamin was previously a managing director at H.C.
Wainwright & Co. and Rodman & Renshaw, after starting his career in biotechnology research at Needham & Company.
He is a past member of the UAB School of Health Professions Dean's Advisory Board.
Dr. Benjamin holds a Ph.D.
in biochemistry and molecular genetics from the University of Alabama at Birmingham and a B.S.
in biology from Allegheny College.

Cargos activos de Reni J. Benjamin

EmpresasCargoInicio
Analyst-Equity 01/08/2019
Director/Miembro de la Junta -
Todos los cargos activos de Reni J. Benjamin

Antiguos cargos conocidos de Reni J. Benjamin.

EmpresasCargoFin
Analyst-Equity 01/08/2019
Analyst-Equity 31/05/2015
Analista de Capital Privado 31/07/2013
Analyst-Equity 01/06/2012
Analyst-Equity -
Ver el detalle de la experiencia de Reni J. Benjamin.

Formación de Reni J. Benjamin.

The University of Alabama at Birmingham Doctorate Degree
Allegheny College Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Reni J. Benjamin.

Relaciones

97

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas7

Finance

Finance

Finance

Finance

Finance

Finance

Health Technology

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Reni J. Benjamin
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA